Home » Topics » Disease categories and therapies » Immune

Immune
RSS

BioSante signs option license agreement with ID Biomedical for vaccine delivery

June 29, 2000

Aquila receives SBIR grant to use CD1 technology in pursuit of Chlamydia vaccine

June 29, 2000

Human Genome Sciences initiates clinical trials of BLyS one year after discovery

June 27, 2000

Aviron and NIH extend FluMist agreement

June 27, 2000

PNU-190192 and related indolylpyrrolidinemethylpyrrole derivatives as immunosuppressants

June 26, 2000

Celgene and NCI to enter into cooperative R&D agreement for IMiDs

June 26, 2000

Merck Frosst launches Varivax II for protection against chickenpox

June 23, 2000

Meningococcal C conjugate vaccine shown to be safe and immunogenic in infants

June 23, 2000

Licensing opportunity from NIH: polypeptides interacting with formyl peptide receptors

June 22, 2000

BioChem Pharma and Cytovax sign collaborative agreement

June 21, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
CC-3 antibody shows antitumoral activity in penile cancer
BioWorld Science
Advanced penile cancer (PeCa) is a rare cancer affecting the genitourinary tract with a 5-year survival rate of about 10% when metastatic. First-line therapies...